Patent Classification
 

Drug Delivery System, Biologically Active Agent

1. Labile linkage for compound delivery to a cell
    
2. Composition for delivery of biological agents and methods for the preparation thereof
    
3. Methods and compositions for delivering macromolecules to or via the respiratory tract
    
4. Stabilized bioactive peptides and methods of identification, synthesis and use
    
5. Delivery of therapeutic biologicals from implantable tissue matrices
    
6. Process for generating multilayered particles
    
7. Bioactive agent release coating
    
8. Buccal, polar and non-polar spray or capsule
    
9. Intracellular delivery of biological effectors
    
10. Slow release protein polymers
     
11. Method, arrangement and use of an implant for ensuring delivery of bioactive substance to the bone and/or tissue surrounding the implant
     
12. Bioimplant formulation
     
13. Composite nanospheres and their conjugates with biomolecules
     
14. Chimeric proteins for use in transport of a selected substance into cells
     
15. High efficient delivery of a large therapeutic mass aerosol
     
16. Method for the preservation of biologically-active material
     
17. N,N-dinitramide salts as solubilizing agents for biologically active agents
     
18. Stabilized bioactive peptides and methods of identification, synthesis and use
     
19. Biologically active conjugates having a detectable reporter moiety and method of identification of the derivative
     
20. Polymer compositions containing bioactive agents and methods for their use
     
21. Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
     
22. Methods and compositions for enhanced delivery of bioactive molecules
     
23. Biodegradable macromers for the controlled release of biologically active substances
     
24. Slow release protein polymers
     
25. Starch microparticles
     
26. Method of stabilizing biologically active substances
     
27. Ionically formulated biomolecule microcarriers
     
28. Delivery of biologically active polypeptides
     
29. Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone
     
30. Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
     
31. Modified red blood cell that has surface molecules that neutralize chemical agents
     
32. Method for importing biologically active molecules into cells
     
33. Treating medical conditions by polymerizing macromers to form polymeric materials
     
34. Covalent microparticle-drug conjugates for biological targeting
     
35. Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
     
36. Pharmaceutical compositions comprised of stabilized peptide particles
     
37. Method of producing sub-micron particles of biologically active agents and uses thereof
     
38. Method for increasing the serum half-life of a biologically active molecule
     
39. Encapsulation of bioactive agents
    
    
40. Multicomponent biological vehicle
    
    
41. Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting
     
    
42. Materials and methods for making improved micelle compositions
     
    
43. Bioconjugates and delivery of bioactive agents
     
    
44. Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
     
    
45. Process for making submicron particles
     
    
46. Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
     
    
47. Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
     
    
48. Method of producing sub-micron particles of biologically active agents and uses thereof
     
    
49. Composition and method for delivery of biologically-active factors
     
    
50. Gels for encapsulation of biological materials
     
    
51. Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
     
    
52. 1gG /transferrin receptor fusion protein
     
    
53. Compounds containing biologically active silicon, which are under solid form
     
    
54. Tocopherol compositions for delivery of biologically active agents
     
    
55. Biologically-active polymers
     
    
56. Materials and methods for intracellular delivery of biologically active molecules
     
    
57. Synthesis of polymer bio-active conjugates
     
    
58. Liposomal delivery system for biologically active agents
     
    
59. Suspensions of microcapsules containing biologically active ingredients and adhesive microspheres
     
    
60. Receptor ligand-facilitated delivery of biologically active molecules
     
    
61. Oral delivery composition comprising supramolecular complex
     
    
62. Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting
     
    
63. Bactericidal/permeability-increasing protein (BPI) compositions
     
    
64. Water-soluble compositions of bioactive lipophilic compounds
     
    
65. Method for importing biologically active molecules into cells
     
    
66. Composition for delivering bioactive agents for immune response and its preparation
     
    
67. Conjugates of biologically active substances
     
    
68. Protein-containing polymer composition for oral administration
     
    
69. Cochleate delivery vehicles
     
    
70. Cationic lipids and methods of use therefore
     
    
71. Diketopiperazine-based delivery systems

Drug Delivery System, Biological Glue

1. Method for preparing thrombin for use in a biological glue

Drug Delivery System, Biphasic

1. Biphasic controlled release delivery system for high solubility pharmaceuticals and method

Drug Delivery System, Buccal

1. Methods of administering and enhancing absorption of pharmaceutical agents
    
2. Method for administering insulin to the buccal region
    
3. Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
    
4. Buccal, polar and non-polar spray or capsule
    
5. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
    
6. Pharmaceutical compositions for buccal delivery of pain relief medications
    
7. Water soluble film for oral administration with instant wettability
    
8. Slow-release disposable elastomeric buccal devices
    
9. Buccal and sublingual administration of physostigmine
    
   
10. Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility
     
    
11. Buccal drug administration in female hormone replacement therapy
     
    
12. Contraceptive method employing buccal delivery of steroidal active agents 
     
    
13. Sublingual buccal effervescent
     
    
14. Buccal drug delivery system for use in male contraception
     
    
15. Drug dosage unit for buccal administration of steroidal active agents
     
    
16. Buccal polar spray or capsule
     
    
17. Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility
     
18. Buccal non polar spray or capsule

Drug Delivery System, Capsid

1. AAV capsid vehicles for molecular transfer

Drug Delivery System, Capsules/Soft Gelatin Capsules/Caplets

1. Diclofenac sodium oral pharmaceutical
    
2. Ultrasonic concentration of drug delivery capsules
    
3. Method for preparing colloidal particles in the form of nanocapsules
    
4. Sensitive substance encapsulation
    
5. Soft capsule preparation
    
6. Non-gelatinous capsule shell composition and a capsule formed from the same
    
7. Delivery system and a manufacturing process of a delivery system
    
8. Seamless filled capsules
    
9. Treatment and control of dry eye by use of biodegradable polymer capsules
    
10. Antihistamine formulations for soft capsule dosage forms
     
11. Hollow capsule having a wall permeable to water or an aqueous solution
     
12. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
     
13. Enteric and colonic delivery using HPMC capsules
     
14. Subcoated simulated capsule-like medicament
     
15. Soft gelatin capsule manufacture
     
16. Acetaminophen compositions
     
17. Hyaluronic acid in soft gel form
     
18. Capsules containing vital cells or tissues
     
19. Cyclosporin-based pharmaceutical compositions
     
20. Biologically active oral preparation that can be site-specific released in colon
     
21. Non-gelatin capsule shell formulation
     
22. Formulation and manufacturing process for coenzyme Q10 soft gel capsules
     
23. Gelatin soft capsule having the properties of removal of oral smell and cleaning of oral cavity
     
24. Hyaluronic Acid in soft gel form
     
25. Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule
     
26. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
     
27. Pulverulent mannitol and process for preparing it
     
28. Oil-free pharmaceutical compositions containing cyclosporin A
     
29. Antihistamine formulations for soft capsule dosage forms
     
30. Starch microcapsules for delivery of active agents
     
31. Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups
     
32. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
     
33. Soft gelatin capsule manufacture
     
34. Highly flexible starch-based films
     
35. Polymer film compositions for capsules
     
36. Oil-free pharmaceutical compositions containing cyclosporin A
     
37. Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
     
38. Cellulose capsule using mixed solution of pectin and glycerin and the manufacturing process thereof
    
    
39. Discoloration-resistant vitamin composition
    
    
40. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
    
    
41. Solvent system for enhancing solubility
    
    
42. Double capsule for the administration of active principles in multiple therapies
    
    
43. Molded capsule superior in strength and stability and method for preparing same
     
    
44. Soft gelatin capsule
     
    
45. Chewable soft capsule
     
    
46. Oral cyclosporin formulations
     
    
47. Sensitive substance encapsulation
     
    
48. Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
     
    
49. Supercritical fluid extraction of mould lubricant from hard shell capsules
     
    
50. Soft gelatin capsules containing particulate material
     
    
51. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
     
    
52. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
     
    
53. Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
     
    
54. Comestible capsules having flavored coatings
     
    
55. Gum acacia substituted soft gelatin capsules
     
    
56. Chitosan-containing soft capsule and process for producing the same
     
    
57. Multiple layer softgel
     
    
58. Sustained release theophylline formulations, excipient systems and methods of production
     
    
59. High strength capsules, process of preparing and using the same
     
    
60. Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
     
    
61. Method of manufacturing caplets with a gelatin cover
     
    
62. Subcoated simulated capsule-like medicament
     
    
63. Buccal polar spray or capsule
     
    
64. Terazosin capsules
     
    
65. Cyclosporin formulation
     
    
66. Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
     
    
67. Omeprazole formulation
     
    
68. Gelatin capsule having adjusted water activity
     
    
69. Unit galenical formulation for local hormonotherapy of vaginal dryness
     
    
70. Sustained release capsule and method for preparing the same
     
    
71. Extended release clonidine formulation (capsule)
     
    
72. Chewable soft gelatin-encapsulated pharmaceutical adsorbates
     
    
73. Multiphase soft gelatin dosage form
     
    
74. Tetrahydrolipstatin containing compositions
     
    
75. Method for making a multi-stage drug delivery system
     
    
76. Process for producing porous, controlled-release capsules and encapsulated composition
     
    
77. Cyclosporin-containing pharmaceutical compositions
     
    
78. Microporous macrocapsules
     
    
79. Softgel capsule containing DHA and antioxidants
     
    
80. Chewable softgel oral hygiene product
     
    
81. Pharmaceutical composition

Drug Delivery System, Carrier/Vector/Receptor/Solvent

1. Controlled agglomeration
    
2. Virus-like particles useful as a vector for delivering nucleic acid
    
3. Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
    
   
4. Immunomodulation by genetic modification of dendritic cells and B cells
    
   
5. Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them
    
   
6. Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine
    
   
7. Oral delivery of adeno-associated viral vectors
    
   
8. Entomopoxvirus-vertebrate gene delivery vector and method
    
   
9. Liposomal delivery of AAV vectors
    
   
10. Macromolecular complexes for drug delivery
     
    
11. Pharmaceutical compositions comprising a soluble interleukin-4 receptor
     
    
12. Microsphere encapsulation of gene transfer vectors
     
    
13. Biodegradable copolymer containing .alpha.-hydroxy acid and .alpha.-amino acid units
     
    
14. Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
     
    
15. Phenylbutazone carrier formulation
     
    
16. Disulfide-containing dendritic polymers
     
    
17. Mucosal administration of substances to mammals (*Large document -- long loading time)
     
    
18. Lipophilic carrier systems
     
    
19. Synthetic particulate vectors and preparation process (*Large document -- long loading time)
     
    
20. Solid support matrices containing a toxin binding oligosaccharide
     
    
21. Lipophilic-polycationic delivery systems
     
    
22. Pharmaceutical composition comprised of cisplatin, and processes for making and using same
     
    
23. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof

Drug Delivery System, Cell-Based Delivery

1. Encapsulated cells containing an amplified expression vector as a drug delivery device
    
2. ARPE-19 as a platform cell line for encapsulated cell-based delivery

Drug Delivery System, Cellular, Transport

1. Transcytosis vehicles and enchancers for drug delivery
    
   
2. Materials and methods for the intracellular delivery of substances
    
   
3. Cell-specific molecule and method for importing DNA into a nucleus
    
   
4. Entomopoxvirus-vertebrate gene delivery vector and method
    
   
5. Active agent transport systems
    
   
6. Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes